115 related articles for article (PubMed ID: 3022573)
1. Nuclear DNA content in mammary carcinomas in women aged 35 or younger.
von Rosen A; Fallenius A; Sundelin B; Auer G
Am J Clin Oncol; 1986 Oct; 9(5):382-6. PubMed ID: 3022573
[TBL] [Abstract][Full Text] [Related]
2. [Contents of nuclear Feulgen-DNA in carcinoma of the breast. Cytophotometric analysis].
Ricevuti G; Barni S
Arch Sci Med (Torino); 1983; 140(4):393-400. PubMed ID: 6201153
[TBL] [Abstract][Full Text] [Related]
3. Pure and mixed mucinous breast carcinomas: DNA stemline and prognosis.
Toikkanen S; Eerola E; Ekfors TO
J Clin Pathol; 1988 Mar; 41(3):300-3. PubMed ID: 2834422
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of nuclear DNA analysis in histological sections in mammary carcinoma.
Erhardt K; Auer G; Fallenius A; Folin A; Forsslund G; Silfverswärd C; Zetterberg A
Am J Clin Oncol; 1986 Apr; 9(2):117-25. PubMed ID: 3012992
[TBL] [Abstract][Full Text] [Related]
5. Comparison between histologic type, estrogen receptor, and nuclear DNA content in mammary carcinoma.
Erhardt K; Auer G; Folin A; Silfverswärd C; Skoog L
Am J Clin Oncol; 1986 Feb; 9(1):83-9. PubMed ID: 3006475
[TBL] [Abstract][Full Text] [Related]
6. Cytochemical classification of nonpalpable breast carcinoma.
Fallenius A; Svane G; Auer G; Caspersson TO
Anal Quant Cytol; 1983 Mar; 5(1):9-12. PubMed ID: 6303171
[TBL] [Abstract][Full Text] [Related]
7. Nuclear DNA content, histological grade, and clinical course in patients with nonpalpable mammographically detected breast adenocarcinomas.
Azavedo E; Fallenius A; Svane G; Auer G
Am J Clin Oncol; 1990 Feb; 13(1):23-7. PubMed ID: 2154920
[TBL] [Abstract][Full Text] [Related]
8. Mammary carcinoma. Comparison of nuclear DNA content from in situ and infiltrative components.
Erhardt K; Auer GU
Anal Quant Cytol Histol; 1987 Jun; 9(3):263-7. PubMed ID: 3040031
[TBL] [Abstract][Full Text] [Related]
9. A comparative morphometric and cytophotometric study of intraductal hyperplasia and intraductal carcinoma of the breast.
Norris HJ; Bahr GF; Mikel UV
Anal Quant Cytol Histol; 1988 Feb; 10(1):1-9. PubMed ID: 2833287
[TBL] [Abstract][Full Text] [Related]
10. Assessment of malignancy potential in mammary carcinoma in elderly patients.
von Rosen A; Gardelin A; Auer G
Am J Clin Oncol; 1987 Feb; 10(1):61-4. PubMed ID: 3825995
[TBL] [Abstract][Full Text] [Related]
11. Microfluorometric grading of mammary tumors. A pilot study.
Patek E; Johannisson E; Krauer F; Riotton G
Anal Quant Cytol; 1980 Dec; 2(4):264-71. PubMed ID: 6258463
[TBL] [Abstract][Full Text] [Related]
12. Nuclear DNA content in breast carcinomas with neuroendocrine differentiation.
Nesland JM; Pettersen EO; Fosså SD; Høie J; Johannessen JV
J Pathol; 1986 Nov; 150(3):181-5. PubMed ID: 3027292
[TBL] [Abstract][Full Text] [Related]
13. Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma.
McCarty KS; Barton TK; Fetter BF; Woodard BH; Mossler JA; Reeves W; Daly J; Wilkinson WE; McCarty KS
Cancer; 1980 Dec; 46(12 Suppl):2851-8. PubMed ID: 6256054
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
15. Nuclear DNA measurements on thyroid carcinoma in young patients.
Ekman ET; Bäckdahl M; Löwhagen T; Auer G
Acta Oncol; 1989; 28(4):475-9. PubMed ID: 2789823
[TBL] [Abstract][Full Text] [Related]
16. Cytochemical identification of quiescent and growth-activated tumor cells.
Auer G; Ono J; Caspersson TO
Anal Quant Cytol; 1983 Mar; 5(1):5-8. PubMed ID: 6303170
[TBL] [Abstract][Full Text] [Related]
17. DNA distributions in human normal, precancerous and cancerous breast tissue. I. Ploidy and cell cycle distribution.
Weiss H; Kunde D; Streller B
Arch Geschwulstforsch; 1986; 56(5):373-9. PubMed ID: 3021084
[TBL] [Abstract][Full Text] [Related]
18. Correlation between histopathologic features and estrogen receptor status in primary breast cancer.
Mantouvalos H; Makrygiannakis A; Metallinos C; Yianniou A; Gouskos A
Int J Gynaecol Obstet; 1984 Jun; 22(3):177-9. PubMed ID: 6148273
[TBL] [Abstract][Full Text] [Related]
19. [Laser flow cytofluorometry as a supplementary method of determining the degree of tumor differentiation in breast cancer patients].
Bogatyrev VN; Ermilova VD; Petrova AS
Arkh Patol; 1986; 48(1):44-8. PubMed ID: 2421692
[TBL] [Abstract][Full Text] [Related]
20. Paucity of fibronectin in invasive lobular carcinoma of breast.
D'Ardenne AJ; Barnard NJ
J Pathol; 1989 Mar; 157(3):219-24. PubMed ID: 2538611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
